---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-25-014296"
form_type: "8-K"
ticker: "ZIVO"
cik: "0001101026"
company_name: "Zivo Bioscience, Inc."
filed_at: "2025-12-23T23:59:59+00:00"
generated_at: "2026-05-16T12:13:24.963780+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# CFO Keith Marchiando resigns; William Sullivan appointed Interim CFO

## Summary
- Keith Marchiando resigns as CFO effective Dec 31, 2025; receives $27,040/mo through Dec 31, 2026.
- Marchiando retains option for 150,000 shares at $7.96, exercisable until June 30, 2027; all other options cancelled.
- William A. Sullivan appointed Interim CFO effective Dec 19, 2025 as independent contractor at $285/hour.
- Sullivan's contract is initially 60 days, auto-renewing monthly; no other compensation or equity.
- Marchiando's separation includes confidentiality and non-disparagement obligations.

## SEC filing metadata
- accession: 0001654954-25-014296
- form_type: 8-K
- ticker: ZIVO
- cik: 0001101026
- company_name: Zivo Bioscience, Inc.
- filed_at: 2025-12-23T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1101026/000165495425014296/0001654954-25-014296-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1101026/000165495425014296/zivo_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-25-014296
- JSON: https://secwatch.observer/filing/0001654954-25-014296.json
- Plain text: https://secwatch.observer/filing/0001654954-25-014296.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.